Press Releases

Nov 17, 2020 Assembly Biosciences Appoints Nicole S. White, PhD, as Senior Vice President of Pharmaceutical Development and Manufacturing
Nov 16, 2020 Assembly Biosciences and Door Pharmaceuticals Sign Collaboration and Option Agreement to Develop a Novel Class of HBV Core Protein Modulators
Nov 13, 2020 Assembly Biosciences Presents Data from HBV Core Inhibitor Programs in Poster Sessions at the 2020 AASLD The Liver Meeting Digital Experience™
Nov 06, 2020 Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Nov 05, 2020 Assembly Biosciences Reports Third Quarter 2020 Financial Results and Business Update
Nov 05, 2020 Assembly Biosciences Provides Update on the Ongoing Phase 2 Extension Study of Vebicorvir in Patients with Chronic Hepatitis B Virus Infection
Nov 02, 2020 Multiple Abstracts Highlighting Assembly Biosciences’ Hepatitis B Core Inhibitor Development Programs Accepted for Presentation at the 2020 AASLD The Liver Meeting Digital Experience™
Oct 20, 2020 Assembly Biosciences Appoints Gina Consylman to Board of Directors
Oct 15, 2020 Assembly Biosciences CEO Dr. John McHutchison Named Recipient of the Prestigious Advance 2020 Global Impact Award
Oct 05, 2020 Assembly Biosciences Announces October Conference Participation